Herbal-Review.com

Independent honest reviews of most effective natural herbal supplements

Lilly drug doubles pancreatic cancer survival: study (Reuters)

by @ 7:29 pm on May 31, 2008.

Reuters - Eli Lilly and Co’s chemotherapy drug
Gemzar more than doubled the overall survival for early stage
pancreatic cancer patients five years after surgery to remove
their tumors, according to results from a long-term study
released on Saturday.

Mature Cams Free Nude Chat Free Asian Live Sex Web Cams Naked Live Sex Chat Rezidentiale Anunturi Imobiliare BBW Porn Movies Auto

[link]

09/11/2008: Fish Oils Benefit Heart Patients as Much as Cholesterol Meds?

08/21/2008: Vaccine refusals fuel measles outbreak (Reuters)

08/12/2008: Frankincense a Great Anti Inflammatory Agent for Pain Relief?

06/10/2008: Diabetes UK Elections

08/17/2008: Ginkgo Biloba Review

The URI to TrackBack this entry is: http://herbal-review.com/2008/05/31/lilly-drug-doubles-pancreatic-cancer-survival-study-reuters/trackback/

2 Responses to “Lilly drug doubles pancreatic cancer survival: study (Reuters)”

Lilly drug doubles pancreatic cancer survival: study (Reuters) Says:
May 31st, 2008 at 8:13 pm
[…] Jennifer wrote an interesting post today onHere’s a quick excerptReuters - Eli Lilly and Co’s chemotherapy drug Gemzar more than doubled the overall survival for early stage pancreatic cancer patients five years after surgery to remove their tumors, according to results from a long-term study … […]
ADHD Report» Blog Archive » Lilly drug doubles pancreatic cancer survival: study (Reuters) Says:
May 31st, 2008 at 8:41 pm
[…] unknownReally interesting read I found today:Reuters - Eli Lilly and Co’s chemotherapy drug Gemzar more than doubled the overall survival for early stage pancreatic cancer patients five years after surgery to remove their tumors, according to results from a long-term study … […]